No hay productos en el carrito



Drug Information Handbook with International Trade Names Index
Lacy, C.
20ª Edición Diciembre 2011
Inglés
Tapa blanda
2263 pags
2000 gr
16 x 23 x 6 cm
ISBN 9781591952923
Editorial LEXI COMP
LIBRO IMPRESO
-5%
73,92 €70,22 €IVA incluido
71,08 €67,52 €IVA no incluido
Recíbelo en un plazo de
2 - 3 semanas
Overview
The Drug Information Handbook with International Trade Names Index contains all the content from Lexicomp’s Drug Information Handbook, plus Canadian and International drug monographs for use worldwide! Endorsed by the American Pharmacists Association, (APhA), this easy-to-use reference is compiled especially for the pharmacist, physician or other healthcare professional requiring quick access to comprehensive drug information.
Benefits
The Drug Information Handbook with International Trade Names Index, 20th Edition, contains 1741 drug monographs. Each monograph is supported by up to 37 fields of clinically important pharmacology detail, including dosage, drug interactions, pharmacologic category and warnings/precautions. Brand names are listed alphabetically and cross-referenced by page number to the generic drug monograph. Over 150 pages of appendix information is provided, including a Pharmacologic Category Index and an International Trade Names Index.
Updates to this Edition
- 31 New Drug Monographs
- New Appendix Topic
- Dosing Considerations for the Critically-Ill Patient With Morbid Obesity
- Appendix Updates
- Hyperlipidemia Management
- Anticonvulsant Drugs of Choice
- Oral Dosages That Should Not Be Crushed
Senior Editors
Charles F. Lacy, RPh, MS, PharmD, FCSHP
Dr Lacy is the Vice President for Information Technologies, Professor of Pharmacy Practice, and Professor of Business Leadership at the University of Southern Nevada. In his capacity at the university, Dr. Lacy oversees the directors of the Library and Learning Resources Center and the University Information Systems. Additionally, Dr Lacy is a co-founder of the University. Currently, Dr Lacy is also the Director of International Programs for the university, which includes the College of Pharmacy, the College of Business Administration, and the College of Nursing. Previously, Dr. Lacy was the Facilitative Officer for Clinical Programs for the College of Pharmacy, where he managed the clinical curriculum, clinical faculty activities, student experiential programs, pharmacy residency programs, and the college's continuing education programs.
Prior to co-founding the Nevada College of Pharmacy, Dr Lacy was the Clinical Coordinator for the Department of Pharmacy at Cedars-Sinai Medical Center. With 20 years of clinical experience, he has developed a reputation as an acknowledged expert in drug information, pharmacy practice, and critical care drug therapy.
Dr Lacy received his doctorate from the University of Southern California School of Pharmacy. Presently, Dr Lacy holds teaching affiliations with the University of Southern Nevada, the University of Southern California, the University of the Pacific School of Pharmacy, Western University of Health Sciences School of Pharmacy, Hokkaido College of Pharmacy in Otaru, Japan, and the University of Alberta at Edmonton, School of Pharmacy and Health Sciences.
Dr Lacy is an active member of numerous professional associations including the American Society of Health-System Pharmacists (ASHP), the American College of Clinical Pharmacy (ACCP), the American Society of Consultant Pharmacists (ASCP), the American Association of Colleges of Pharmacy (AACP), American Pharmacists Association (APhA), and the California Society of Hospital Pharmacists (CSHP), through which he has chaired many committees and subcommittees.
Lora L. Armstrong, RPh, PharmD, BCPS
Dr Armstrong received her bachelor's degree in pharmacy from Ferris State University and her Doctor of Pharmacy degree from Midwestern University. Dr Armstrong is a Board-Certified Pharmacotherapy Specialist (BCPS).
In her current position, Dr Armstrong serves as Vice President of Clinical Affairs with responsibility for the National Pharmacy & Therapeutics Committee process, Clinical Program Oversight process, and Pharmaceutical Pipeline Services at Caremark. Caremark is a prescription benefit management company (PBM). Dr Armstrong is also responsible for monitoring drug surveillance and communicating Pharmacy & Therapeutics Committee Formulary information to Caremark's internal and external customers.
Prior to joining Caremark, Inc, Dr Armstrong served as the Director of Drug Information Services at the University of Chicago Hospitals. She obtained 17 years of experience in a variety of clinical settings including critical care, hematology, oncology, infectious diseases, and clinical pharmacokinetics. Dr Armstrong played an active role in the education and training of medical, pharmacy, and nursing staff. She coordinated the Drug Information Center, the medical center's Adverse Drug Reaction Monitoring Program, and the continuing Education Program for pharmacists. She also maintained the hospital's strict formulary program and was the editor of the University of Chicago Hospitals' Formulary of Accepted Drugs and the drug information center's monthly newsletter Topics in Drug Therapy.
Dr Armstrong is an active member of the Academy of Managed Care Pharmacy (AMCP), the American Society of Health-Systems Pharmacists (ASHP), the American Pharmaceutical Association (APhA), the American College of Clinical Pharmacy (ACCP), and the Pharmacy & Therapeutics Society (P & T Society). Dr Armstrong wrote the chapter entitled "Drugs and Hormones Used in Endocrinology" in the 4th edition of the textbook Endocrinology. She is an Adjunct Clinical Instructor of Pharmacy Practice at Midwestern University. Dr Armstrong currently serves on the Drug Information Advisory Board for pharmacist.com and on the American Pharmaceutical Association Scientific Review Panel for Evaluations of Drug Interactions (EDI).
Morton P. Goldman, RPh, PharmD, BCPS, FCCP
Dr Goldman received his bachelor's degree in pharmacy from the University of Pittsburgh, College of Pharmacy and his Doctor of Pharmacy degree from the University of Cincinnati, Division of Graduate Studies and Research. He completed his concurrent 2-year hospital pharmacy residency at the VA Medical Center in Cincinnati. Dr Goldman is presently the Assistant Director of Pharmacotherapy Services for the Department of Pharmacy at the Cleveland Clinic Foundation (CCF) after having spent over 4 years at CCF as an Infectious Disease pharmacist and 4 years as Clinical Manager. He holds faculty appointments from The University of Toledo, College of Pharmacy and Case Western Reserve University, College of Medicine and is the Pharmacology Curriculum Coordinator for the new Cleveland Clinic Lerner College of Medicine. Dr Goldman is a Board-Certified Pharmacotherapy Specialist (BCPS) with added qualifications in infectious diseases.
In his capacity as Assistant Director of Pharmacotherapy Services at CCF, Dr Goldman remains actively involved in patient care and clinical research with the Department of Infectious Disease, as well as the continuing education of the medical and pharmacy staff. He is an editor of CCF's Guidelines for Antibiotic Use and participates in their annual Antimicrobial Review retreat. He is a member of the Pharmacy and Therapeutics Committee and many of its subcommittees. Dr Goldman has authored numerous journal articles and lectures locally and nationally on infectious diseases topics and current drug therapies. He is currently a reviewer for the Annals of Pharmacotherapy and the Journal of the American Medical Association, an editorial board member of the Journal of Infectious Disease Pharmacotherapy, and coauthor of the Infectious Diseases Handbook and the Drug Information Handbook for the Allied Health Professional produced by Lexi-Comp, Inc. He also provides technical support to Lexi-Comp's Clinical Reference Library publications.
Dr Goldman is an active member of the Ohio College of Clinical Pharmacy, the Society of Infectious Disease Pharmacists, the American College of Clinical Pharmacy (and is a Fellow of the College), and the American Society of Health-Systems Pharmacists.
Leonard L. Lance, RPh, BSPharm
Leonard L. (Bud) Lance has been directly involved in the pharmaceutical industry since receiving his bachelor's degree in pharmacy from Ohio Northern University in 1970. Upon graduation from ONU, Mr Lance spent four years as a navy pharmacist in various military assignments and was instrumental in the development and operation of the first whole hospital I.V. admixture program in a military (Portsmouth Naval Hospital) facility. His last 15 months in the Navy were spent on the USS Independence CV-62.
After completing his military service, he entered the retail pharmacy field and has managed both an independent and a home I.V. franchise pharmacy operation. Since the late 1970s, Mr Lance has focused much of his interest on using computers to improve pharmacy service. The independent pharmacy he worked for was one of the first retail pharmacies in the State of Ohio to computerize (1977).
His love for computers and pharmacy lead him to Lexi-Comp, Inc. in 1988. He was the first pharmacist at Lexi-Comp and helped develop Lexi-Comp's first drug database in 1989 and was involved in the editing and publishing of Lexi-Comp's first Drug Information Handbook in 1990.
As a result of his strong publishing interest, he presently serves in the capacity of pharmacy editor and technical advisor as well as pharmacy (information) database coordinator for Lexi-Comp. Along with authoring Lippincott Williams & Wilkins' Quick Look Drug Book, he provides technical support to Lexi-Comp's reference publications. Mr Lance also assists over 300 major hospitals in producing their own formulary (pharmacy) publications through Lexi-Comp's custom publishing service. Mr Lance is also Manager of the Dosage Forms Database in the Medical Sciences Division at Lexi-Comp.
Mr Lance is past president (1984) of the Summit Pharmaceutical Association (SPA). He is a member of the Ohio Pharmacists Association (OPA), the American Pharmaceutical Association (APhA), and the American Society of Health-System Pharmacists (ASHP).
© 2025 Axón Librería S.L.
2.149.0